510(k) Report

510(k) · Cleared

Cleared

Wallstent Transhepatic Biliary Endoprosthesis

K982005510(k) TraditionalCleared Sep 2, 199886-day reviewClass II21 CFR 876.5010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boston Scientific Scimed, Inc. · FGE Stents, Drains And Dilators For The Biliary Ducts

Cleared on Sep 2, 1998 as substantially equivalent to K923993 (Schneider U.S. Stent Div., 1994) and 2 other predicates after an 86-day review. Its family tree reaches back 3 generations to 1991.

Decided
Sep 2, 1998
Review
86 days
Class
Class II
Product code
FGE
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K911292 (1991). 5 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK911292 Schneider Wallstent (R)Pfizer Hospital Products Group, Inc. · 1991
  2. 2 generations backK961262 Wallstent Transhepatic Biliary Endoprosthesis/Wallstent Endoscopic…Boston Scientific Scimed, Inc. · 1996
  3. 1 generation backK964119 Wallstent Transhepatic Biliary EndoprosthesisBoston Scientific Scimed, Inc. · 1997 · Recalled
  4. This deviceK982005 Wallstent Transhepatic Biliary EndoprosthesisBoston Scientific Scimed, Inc. · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K911292Schneider Wallstent (R)Pfizer Hospital Products Group, Inc.1991—
−2K961262Wallstent Transhepatic Biliary Endoprosthesis/Wallstent Endoscopic Biliary…Boston Scientific Scimed, Inc.1996—
−1K964119Wallstent Transhepatic Biliary EndoprosthesisBoston Scientific Scimed, Inc.19976
0 (this device)K982005Wallstent Transhepatic Biliary EndoprosthesisBoston Scientific Scimed, Inc.1998—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199410
FIG. 1 — Lineage of K982005, 1991–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FGE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FGE device

  1. #1 K240464 WallFlex Biliary RX Stent System; Epic Biliary…score 14.5 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K923993Wallstent Biliary Endoprotheses
Summary page 1
…Delivery System Common Name Biliary Stent Classification Class II Predicate Devices WALLSTENT® Biliary Transhepatic Endoprosthesis with Unistep™ Plus Delivery System — K923993, K961262, K964119 Device Description The WALLSTENT® Biliary Endoprosthesis is a self-expanding prosthesis constructed of biomed…
Schneider U.S. Stent Div.1994—
*K961262Wallstent Transhepatic Biliary Endoprosthesis/Wallstent Endoscopic Biliary Endoprosthesis
Summary page 1
…System Common Name Biliary Stent Classification Class II Predicate Devices WALLSTENT® Biliary Transhepatic Endoprosthesis with Unistep™ Plus Delivery System — K923993, K961262, K964119 Device Description The WALLSTENT® Biliary Endoprosthesis is a self-expanding prosthesis constructed of biomedical supe…
Boston Scientific Scimed, Inc.1996—
*K964119Wallstent Transhepatic Biliary Endoprosthesis
Summary page 1
…ommon Name Biliary Stent Classification Class II Predicate Devices WALLSTENT® Biliary Transhepatic Endoprosthesis with Unistep™ Plus Delivery System — K923993, K961262, K964119 Device Description The WALLSTENT® Biliary Endoprosthesis is a self-expanding prosthesis constructed of biomedical superalloy an…
Boston Scientific Scimed, Inc.19976
†K980163Wallstent Tracheobronchial Endoprosthesis and Wallstent Tracheobronchial Endoprosthesis…Boston Scientific Scimed, Inc.19981

Also cleared against K923993: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 1.3 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • 3 other devices also cite its predicate K923993.

How does its category compare?

All FGE devices

FGE Stents, Drains And Dilators For The Biliary Ducts: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FGE

7in 2025

2007: 42008: 112009: 72010: 92011: 92012: 82013: 52014: 82015: 82016: 42017: 92018: 72019: 22020: 42021: 12022: 62023: 62024: 62025: 72026 (partial year): 8
2007high 11 (2008) · low 1 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FGE

257in 2025

2007: 316 days median2008: 214 days median2009: 160 days median2010: 81 days median2011: 114 days median2012: 96 days median2013: 161 days median2014: 156 days median2015: 79 days median2016: 49 days median2017: 59 days median2018: 215 days median2020: 121 days median2022: 101 days median2023: 199 days median2024: 188 days median2025: 257 days median2026 (partial year): 153 days median
2007high 316 (2007) · low 49 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FGE

1in 2024

2007: 542008: 932009: 182010: 322011: 22012: 42013: 32017: 12018: 432019: 132020: 12021: 272022: 212023: 192024: 12026 (partial year): 11
2007high 93 (2008) · low 0 (2014)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FGE

1,923in 2025

2007: 1,0062008: 1,4652009: 1,6552010: 1,4342011: 1,3212012: 1,1832013: 1,0602014: 1,2702015: 1,5432016: 1,4532017: 1,5152018: 1,6812019: 1,8962020: 2,1822021: 2,2972022: 1,7492023: 1,6152024: 1,9482025: 1,923
2007high 2,297 (2021) · low 1,006 (2007)2025

MAUDE reports naming product code FGE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074316541,006
200811214931,465
20097160181,655
2010981321,434
2011911421,321
201289641,183
2013516131,060
2014815601,270
201587901,543
201644901,453
201795911,515
20187215431,681
20192—131,896
2020412112,182
20211—272,297
20226101211,749
20236199191,615
2024618811,948
2025725701,923
2026815311—

What is it indicated for?

The Schneider WALLSTENT® Biliary Endoprosthesis is indicated for use in the treatment of biliary strictures produced by malignant neoplasms.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K982005: Wallstent Transhepatic Biliary Endoprosthesis.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K982005

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026